Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

Executives on a DealBook Summit task force panel said fear was not the way to build teams capable of navigating difficult ...

Chronic chikungunya arthritis often mimics rheumatoid arthritis, complicating diagnosis and therapy, and necessitating ...

The boss of Britain’s largest drug developer has praised the US as the best place to invest amid fears over the waning appeal ...

Harvey Jones asked artificial intelligence to prepare a portfolio of FTSE 100 stocks to yield him a passive income in ...

DelveInsight’s “Post Traumatic Stress Disorder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an ...

GlaxoSmithKline’s overall stock score is driven by strong financial performance and favorable valuation metrics. The company’s strategic initiatives, including share buybacks and R&D investments, ...

GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK has announced that the US FDA approved Blujepa (gepotidacin), a new ...

The Non-Opioid Therapeutics Market is rapidly expanding due to increased demand for safer pain management Non-Opioid Therapeutics Market Non-Opioid Therapeutics Market Dublin, Dec. 11, 2025 (GLOBE ...

People with dementia who received a shingles vaccine were significantly less likely to die from dementia than those who ...

Regulators have the authority to penalize false advertising. What they cannot do is enact rules so heavy that legitimate ads cannot run.

In a separate development, GSK plc (NYSE:GSK) announced on November 20 that its subsidiary, TESARO, Inc., confirmed the ...